Product image of Nebilet (Nebivolol) supplied by GNH India

Nebilet

Active Ingredient:
Nebivolol
Origin:
EU

Nebilet (Nebivolol)

Nebivolol, the active ingredient in Nebilet, is a beta blocker presented as an oral tablet for oral use. It helps lower blood pressure and improve heart function in adults with hypertension or heart failure.

GNH India supplies Nebilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Berlin-Chemie Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nebilet is a selective β1‑adrenergic blocker used in cardiovascular disease management.

  • Hypertension: lowers systolic and diastolic blood pressure in adults.
  • Heart failure: improves cardiac output and reduces symptoms of reduced‑ejection‑fraction heart failure.
  • Elderly patients with hypertension: provides effective blood‑pressure control with a favorable metabolic profile.

How It Works

  • Nebivolol selectively antagonizes β1‑adrenergic receptors, reducing heart rate and myocardial contractility, which lowers cardiac output and blood pressure. In addition, it stimulates endothelial nitric oxide release, causing vasodilation and further contributing to its antihypertensive effect without significant β2 blockade.

Side Effects

Nebilet may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Headache: mild to moderate pain often occurring early in therapy.
  • Fatigue: feeling of tiredness or reduced energy.
  • Dizziness: light‑headed sensation, especially on standing.
  • Bradycardia: slower than normal heart rate.
  • Nasal congestion: blocked or runny nose.
  • Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

  • Severe bradycardia: markedly slow heart rate requiring medical attention.
  • Hypotension: significant drop in blood pressure leading to fainting.
  • Heart block: impairment of electrical conduction in the heart.
  • Bronchospasm: narrowing of airways, especially in patients with asthma.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Hepatic dysfunction: abnormal liver enzymes or liver injury.

Precautions & Warnings

Before initiating Nebilet, clinicians should evaluate patient‑specific factors and monitor therapy.

  • Cardiovascular assessment: monitor heart rate and blood pressure regularly.
  • Respiratory conditions: use cautiously in patients with asthma or chronic obstructive pulmonary disease.
  • Renal impairment: consider dose adjustment in moderate to severe renal dysfunction.
  • Drug interactions: review concomitant medications for potential additive effects.
  • Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Nebilet can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Non‑selective beta‑blockers: additive bradycardia and hypotension.
  • Calcium channel blockers (verapamil, diltiazem): risk of severe bradycardia.
  • Clonidine abrupt withdrawal: may precipitate rebound hypertension.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may enhance hypotensive effect.
  • Diuretics: increase risk of orthostatic hypotension.
  • Antidiabetic agents: may mask hypoglycemia symptoms.

Frequently Asked Questions

Nebilet, containing nebivolol, is prescribed for adults with essential hypertension and for patients with heart failure with reduced ejection fraction. It helps lower blood pressure and improve cardiac function, reducing the risk of cardiovascular complications.

Nebivolol selectively blocks β1‑adrenergic receptors, decreasing heart rate and contractility, which reduces cardiac output. It also enhances nitric oxide release from the endothelium, causing vasodilation and further lowering systemic vascular resistance.

The dose of Nebilet is individualized by the prescribing clinician based on the patient’s condition, age, renal function, and response to therapy. Dosage adjustments are made according to clinical guidelines and patient tolerance.

Safety of nebivolol in pregnancy and lactation has not been fully established. It should be avoided unless the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Nebilet product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nebilet (nebivolol) offers β1‑selectivity combined with nitric‑oxide‑mediated vasodilation, which may result in fewer metabolic side effects compared with non‑selective beta‑blockers. Its dual mechanism can provide effective blood‑pressure control while preserving endothelial function.

Nebilet tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability.

Nebilet is taken orally, usually once daily, with or without food, as directed by the prescribing physician. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe bradycardia, marked hypotension, heart block, bronchospasm in susceptible individuals, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, difficulty breathing, or swelling.

Nebilet is contraindicated in patients with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, and individuals in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or severe chronic obstructive pulmonary disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nebivolol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT